Original Research
Accepted on 19 Jun 2025
Cost-utility analysis of empagliflozin compared with dapagliflozin in patients with type 2 diabetes in China
in Health Economics
Original Research
Accepted on 19 Jun 2025
in Health Economics
Systematic Review
Accepted on 19 Jun 2025
in Human-Media Interaction
Original Research
Accepted on 19 Jun 2025
in Healthcare Professions Education
Original Research
Accepted on 19 Jun 2025
in Asthma
Original Research
Accepted on 19 Jun 2025
in Hepatobiliary Diseases
Original Research
Accepted on 19 Jun 2025
in Political Participation
Original Research
Accepted on 19 Jun 2025
in Ocean Observation
Original Research
Accepted on 19 Jun 2025
in Life-Course Epidemiology and Social Inequalities in Health
Original Research
Accepted on 19 Jun 2025
in Plant Systematics and Evolution
Original Research
Accepted on 19 Jun 2025
in Rheumatology
Original Research
Accepted on 19 Jun 2025
in Emotion Science
Original Research
Accepted on 19 Jun 2025
in Pediatric Cardiology
Original Research
Accepted on 19 Jun 2025
in Plant Breeding
Original Research
Accepted on 19 Jun 2025
in Antigen Presenting Cell Biology
Original Research
Accepted on 19 Jun 2025
in Inflammation Pharmacology
Review
Accepted on 19 Jun 2025
in Pain Mechanisms and Modulators